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KEY OPINION LEADERS’ VIEWS REGARDING
EMERGENCY CONTRACEPTION IN INDIA
By M.E. Khan, Isha Bhatnagar, Deepthi S. Varma, Anvita Dixit

BACKGROUND
The emergency contraception pill (ECP) was
approved and introduced in the National Family
Planning Program in 2002 and made available
over the counter (OTC) in 2005. The first phase
of this study on ECP providers in urban areas
revealed that providers lack correct knowledge
and often are not in favor of the easy availability
of ECP to young and unmarried women. Concern
about repeated use of ECP was also identified
as an issue.

OBJECTIVE
This study explores the views of key opinion
leaders (KOLs) in the field of reproductive health
and family welfare. The objective is to gain a
better understanding of how the attitudes and
beliefs of KOLs might influence policy and
program implementation, either encouraging or
opposing ECP promotion and service delivery.

METHODOLOGY
A qualitative approach was used to interview 19
experts from Agra, Delhi, and Lucknow. Eight of
these key opinion leaders were OB/GYNS from
medical institutions, seven were government
employees (senior program managers of the
Ministry of Health and Family Welfare of Uttar
Pradesh state and the central government),
three were from development organizations, and
one was from an ECP manufacturing firm.

An interview guideline was followed and
interviews were recorded. Detailed notes were
taken when informants were reluctant to have
their opinions tape recorded.
Topics discussed included perceptions of the
safety and effectiveness of ECP, attitudes toward
appropriate contexts for use, reservations among
providers, the association between access to
ECP and promiscuity and premarital sex, and
repeated use as a substitute for modern
contraceptive methods. Recommendations to
increase access and suggestions for further
research were also discussed.

FINDINGS
•

All eight OB/GYNS reported that ECP is a
safe and effective product that works by
delaying or inhibiting ovulation. Government
and program officials were not as certain
regarding the mechanism of action of ECP.

•

Eight KOLs expressed that ECP use is
appropriate in the case of contraceptive
failure, and two felt that it is appropriate for
women who have infrequent sexual
relations. Thirteen KOLs considered use
appropriate only in emergencies.

•

Seven respondents felt that use should be
permitted for any woman regardless of her age or
marital status. The other respondents were in
support of one or another restriction.

•

Three respondents related premarital sex and
promiscuity to ECP availability, ten deemed this
association to be a misconception, and six were
uncertain (and did not express a firm opinion).

•

Eleven KOLs believed that increased availability of
ECP will not lead to its becoming a substitute for
regular contraceptive methods, and some believed
it would foster use of other methods. As one
respondent noted, “In my experience, if ten women
have taken ECP, then eight would go for a regular
method, so users do move to regular methods.”
Eight KOLs were concerned that it may push
clients away from regular contraception.

•

KOLs’ perceptions of challenges to ECP provision
among providers include lack of knowledge and
lack of training (11), little counseling time (5),
insufficient access to ECP in rural areas (9), and
low program focus (4).

•

All KOLs were concerned about repeated use, but
their definitions of repeated use and their
perceptions of the frequency of its occurrence
varied.

•

Five out of 19 expressed concern about OTC
availability and were worried about negative
consequences of repeat use, such as menstrual
disturbance or ECP failure. “When they come to us
with abdominal pain or irregular bleeding, we find
out that they were taking ECP many times in a
cycle and mistaking irregular bleeding as
menstrual bleeding, not realizing what repeat use
was doing to their body.” But six out of nine
OB/GYNS expressed that ECP may lead to a
decline in abortions.

•

Thirteen KOLs stated that media messages need
to emphasize that ECP is for emergency use only.

They also noted that adoption of modern
contraceptive methods should be encouraged
following ECP use, and that the side effects of
repeated use need to be highlighted.
•

KOLs suggested that further research be
conducted on the failure rate of ECP due to
repeat use, and the extent to which ECP use
reduces abortion. One OB/GYN asked for a
study to rule out whether ECP leads to ectopic
pregnancy. Other suggestions included
studying the extent to which ECP use is
replacing use of other methods, the profile of
repeat users, and the impact of repeated use
on abortions.

POLICY IMPLICATIONS
These results suggest strong support by the
majority of KOLs to continue the sale of ECP as an
OTC drug. KOLs also emphasized the importance of
comprehending and addressing the main barriers
to ECP provision and use: poor knowledge, lack of
training, moral reservations, biases, and misuse.
The majority of KOLs felt that use of ECP two or
three times in one menstrual cycle was acceptable.
They highlighted the need for empirical evidence to
support their impression that use of regular family
planning methods has not declined as a result of
ECP use, and that use of ECP does not lead to
increased promiscuity.
The KOL interviews also suggest the need for a
strong ECP advocacy campaign, targeting providers
as well as prospective users. Creating guidelines
and clarifying ambiguities would reduce concerns
among providers regarding repeated use of ECP
replacing regular contraception and that an
increased ECP use will increase promiscuity. And
given that the majority of ECP users are educated
urban young women who are upper-middle class or
wealthy, such a campaign should target use among
poorer women in rural areas.

The Population Council confronts critical health and development issues—from stopping the spread of HIV to improving reproductive health and ensuring
that young people lead full and productive lives. Through biomedical, social science and public health research in about 50 countries, the Council works
with our partners to deliver solutions that lead to more effective policies, programs, and technologies to improve lives worldwide. Established in 1952 and
headquartered in New York, the Council is a nongovernmental, nonprofit organization with an international board of trustees.

www.popcouncil.org
© 2012 The Population Council, Inc.

Population Council, Zone 5A, Ground Floor
India Habitat Centre, Lodi Road, New Delhi – 110003

